These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9451687)

  • 1. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of girls with ornithine transcarbamylase deficiency.
    Maestri NE; Brusilow SW; Clissold DB; Bassett SS
    N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new therapy for portal systemic encephalopathy.
    Mendenhall CL; Rouster S; Marshall L; Weesner R
    Am J Gastroenterol; 1986 Jul; 81(7):540-3. PubMed ID: 3717115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantation.
    Berry GT; Bridges ND; Nathanson KL; Kaplan P; Clancy RR; Lichtenstein GR; Spray TL
    Arch Neurol; 1999 Apr; 56(4):481-4. PubMed ID: 10199339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urea cycle disorders.
    Batshaw ML; Monahan PS
    Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperammonaemic coma in ureterosigmoid urinary diversion.
    Oliver RM; Talbot S; Raman GV
    Postgrad Med J; 1989 Jul; 65(765):502-4. PubMed ID: 2602245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of 10% sodium benzoate plus 10% sodium phenylacetate with various flavored vehicles.
    Gutteridge C; Kuhn RJ
    Am J Hosp Pharm; 1994 Oct; 51(19):2508, 2510. PubMed ID: 7847413
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.
    Bunchman TE; Barletta GM; Winters JW; Gardner JJ; Crumb TL; McBryde KD
    Pediatr Nephrol; 2007 Jul; 22(7):1062-5. PubMed ID: 17277951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of severe carbamyl phosphate synthetase I deficiency.
    Van de Bor M; Mooy P; van Zoeren D; Berger R; van Gelderen HH; Teijema HL
    Arch Dis Child; 1984 Dec; 59(12):1183-5. PubMed ID: 6524951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late clinical presentation of partial carbamyl phosphate synthetase I deficiency.
    Lo WD; Sloan HR; Sotos JF; Klinger RJ
    Am J Dis Child; 1993 Mar; 147(3):267-9. PubMed ID: 8438805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperammonemia with sodium benzoate.
    Kodama H; Kamoshita S; Motokawa Y
    J Pediatr; 1983 Sep; 103(3):498. PubMed ID: 6886925
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of severe hyperammonemia using sodium phenylacetate powder prepared in hospital pharmacy.
    Honda S; Yamamoto K; Sekizuka M; Oshima Y; Nagai K; Hashimoto G; Kaneko H; Tomomasa T; Konno Y; Horiuchi R
    Biol Pharm Bull; 2002 Sep; 25(9):1244-6. PubMed ID: 12230130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
    Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
    Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of sodium benzoate in newborn infants with hyperammonemia.
    Green TP; Marchessault RP; Freese DK
    J Pediatr; 1983 May; 102(5):785-90. PubMed ID: 6842341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.